ArticleBMC pulmonary medicine2026
Pseudo-obstruction on single-phase CTPA: unilateral pulmonary vein atresia as the cause of 50 years of hemoptysis.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundHemoptysis in adults is rarely caused by congenital vascular anomalies, leading to frequent diagnostic oversight. Unilateral pulmonary vein atresia is a rare congenital anomaly in adults that may mimic chronic thromboembolic pulmonary disease (CTEPD) on single-phase computed tomography pulmonary angiography (CTPA). This radiologic mimicry frequently leads to misdiagnosis and inappropriate anticoagulation. We report a case illustrating this diagnostic pitfall and the critical role of dual-phase imaging. CASE PRESENTATION: A 58-year-old woman presented with worsening hemoptysis. Despite a 50-year history of intermittent bleeding, she had recently been diagnosed with CTEPD based on flow artifacts mimicking filling defects seen on single-phase CTPA and started on oral anticoagulants, which exacerbated her symptoms. The discordance between the extensive radiological occlusion and her stable cardiopulmonary status prompted re-evaluation. Dual-phase CTPA demonstrated delayed arterial opacification and absent pulmonary veins, confirming congenital unilateral pulmonary vein atresia. The initial "thrombus" was identified as a flow artifact caused by hemodynamic stasis. Anticoagulation was immediately ceased. The patient underwent successful superselective embolization of hypertrophied systemic collaterals. She remained asymptomatic at follow-up.
conclusionsCongenital unilateral pulmonary vein atresia can simulate pulmonary embolism on pulmonary arterial-phase imaging, creating a pseudo-obstruction. Clinicians should suspect this anomaly in adults with long-standing hemoptysis when imaging findings of extensive thrombosis do not align with clinical presentation. Dual-phase CTPA is the critical problem-solving tool to differentiate true pulmonary artery thromboembolism from flow artifacts, thereby preventing dangerous anticoagulation and guiding appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.